Allen Ho, MD
Ophthalmology · Plymouth Meeting, PANPI 1922056712
Payments from drug & device makers
Across 251 payments — averaging $5187.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$732K
- Novartis$269K
- Regeneron$91K
- Aerie Pharmaceuticals, Inc.$37K
- Alcon Research LLC$35K
- AbbVie$30K
- plus $108K from 20 others
Across 4 payments — averaging $1926.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$5K
- Regeneron$2K
What the payments were for
- Consulting fees$205,46991%
- Speaking & faculty fees$6,2973%
- Travel & lodging$6,9973%
- Food & beverage$6,3313%
- Gifts$1420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 48 | $731,772 |
| Novartis | 9 | $268,827 |
| Regeneron | 44 | $90,672 |
| Aerie Pharmaceuticals, Inc. | 14 | $37,113 |
| Alcon Research LLC | 18 | $35,329 |
| AbbVie(2 entities) | 16 | $30,191 |
| Regeneron Healthcare Solutions, Inc. | 8 | $29,562 |
| Alcon | 17 | $21,121 |
| Eyepoint US, Inc. | 16 | $15,658 |
| Notal Vision, Inc. | 4 | $10,172 |
| Genentech USA, Inc. | 14 | $8,402 |
| Janssen Research & Development, LLC | 3 | $6,610 |
| Neurotech Pharmaceuticals, Inc. | 4 | $5,876 |
| Apellis Pharmaceuticals, Inc. | 4 | $4,174 |
| Ocular Therapeutix, Inc. | 15 | $3,539 |
| Dompe US, Inc. | 1 | $1,250 |
| Beaver-visitec International, Inc. | 2 | $1,197 |
| Abbott | 1 | $148 |
| Alimera Sciences, Inc. | 3 | $113 |
| Biogen | 1 | $112 |
| Carl Zeiss Meditec, Inc. | 2 | $96 |
| Bausch & Lomb Americas Inc. | 1 | $68 |
| Astellas Pharma US Inc | 1 | $42 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Carl Zeiss Meditec USA, Inc. | 1 | $24 |
| Rapid Pathogen Screening, Inc. | 3 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$86,556
- EYP-1901$15,065
- ForeseeHome$10,125
- Lucentis$7,721
- ARGOS$6,300
- ENCELTO$5,643
- OZURDEX$3,100
- Rocklatan$3,000
- DEXTENZA$1,275
- EYLEA HD$1,105
- Constellation$1,050
- Proclaim IPG$148
- VABYSMO$123
- BUPARLISIB$122
- Syfovre$116
- NGENUITY$113
- BYOOVIZ$112
How this compares
$1,302,095 in reported general payments places this provider in the 95th percentile of 920 ophthalmology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 199 | $11,021 |
| ProlensaBromfenac Sodium | 17 | $5,966 |
| Ketorolac Tromethamine | 210 | $4,826 |
| Brimonidine Tartrate | 19 | $2,123 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 50 | $920 |
| Latanoprost | 43 | $562 |
| Atropine Sulfate | 13 | $497 |
| ErythromycinErythromycin Base | 34 | $374 |
| Dorzolamide Hcl | 14 | $302 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 27 | $229 |
| Timolol Maleate | 22 | $211 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Plymouth Meeting
- Carl RegilloPlymouth Meeting$3.2M
- Sunir GargPlymouth Meeting$2M
- Allen ChiangPlymouth Meeting$1.6M
- Mitchell FinemanPlymouth Meeting$1.3M
- Jason HsuPlymouth Meeting$1M
- Yoshihiro YonekawaPlymouth Meeting$916K
- Michael KlufasPlymouth Meeting$528K
- Sonia MehtaPlymouth Meeting$442K
- Ajay KuriyanPlymouth Meeting$320K
- Mohammed KhanPlymouth Meeting$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.